Trovafloxacin Mesylate Patent Expiration
Trovafloxacin Mesylate is Used for treating bacterial infections. It was first introduced by Pfizer Central Research
Trovafloxacin Mesylate Patents
Given below is the list of patents protecting Trovafloxacin Mesylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Trovan | US5763454 | Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt |
Jun 15, 2015
(Expired) | Pfizer |
| Trovan | US6187341 | Trovafloxacin mesylate tablet |
Jan 20, 2019
(Expired) | Pfizer |